logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Mafalda Oliveira

Vall d'Hebron University Hospital

48H-index
564Paper Count
1.3WCitation Count
Published Papers 178
Publication Date
logo
Body Mass Index in Postmenopausal Women with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: An Exploratory Analysis of the LORELEI trial.
errEuropean Journal of Cancer
IF7.1
err2026-06-12
err0
PREAI
errChiara Dauccia; Maria Alice Franzoi; Cristina Saura; Dominik Hlauschek; Lidija Sölkner; Michael Gnant; Peter C. Dubsky; Ruth Helfgott; Gabriele Zoppoli; Mafalda Oliveira; Laetitia Collet; Jill Fredrickson; Timothy R. Wilson; Luca Arecco; Elisa Agostinetto; Evandro de Azambuja
errShare
errSave
Evolving landscape of targeted therapies in early phase clinical trials
errEuropean Journal of Cancer
IF7.1
err2026-04-12
err0
PREAI
errAlice Rossi; Irene Braña; Maria Vieito; Oriol Mirallas; Victor Navarro; Omar Saavedra; Guzman Alonso Casal; Vladimir Galvao; M Julia Lostes Bardaji; Arjun Oberoi; Giulia Pretelli; Marta Sanz; Sergio Andres Bueno; Benet Fite Abril; Susana Aguilar Izquierdo; Jose Jimenez; Paolo Nuciforo; Ana Vivancos; Mafalda Oliveira; Iosune Baraibar
errShare
errSave
Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)
errNature Communications
IF15.7
err2026-02-16
err0
errOAAI
errTomás Pascual; Maria Vidal; Juan M. Cejalvo; Estela Vega; Esther Sanfeliu; Guillermo Villacampa; Sergi Ganau; Ana María Julve Parreño; Esther Zamora; Ignacio Miranda; Ana Delgado; Begoña Bermejo; Elia Seguí; Fara Brasó-Maristanty; Luis de la Cruz-Merino; Manel Juan; Patricia Galván; Xavier Gonzàlez-Farré; Samyukta Chillara; Patricia Villagrasa; Adam D. Pfefferle; Constandina E. O’Connell; Juan M. Ferrero-Cafiero; Mafalda Oliveira; Charles M. Perou; Aleix Prat
errShare
errSave
Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1☆
errESMO Open
IF8.3
err2026-01-21
err0
errOAAI
errC. Vaklavas; M. Oliveira; A.C. Armstrong; I. Moreno; C. Twelves; I. Victoria Ruiz; B. Bermejo de las Heras; T. Brier; C. Ciardullo; L. Gibbons; T. Jack; T. Klinowska; J.P.O. Lindemann; A.M. Mathewson; R. Maudsley; C.J. Morrow; A. Sykes; R.D. Baird
errShare
errSave
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis
errCancer Treatment Reviews
IF10.5
err2025-12-03
err0
PREAI
errAlicia Escudero; Meritxell Bellet; Cristina Saura; Anna Aguilera; Andri Papakonstantinou; Pablo Tolosa; José Ángel García-Sáenz; Fernando Moreno; Alfonso López de Sá; Francesco Schettini; Elia Seguí; Marta Gonzalez-Rodriguez; Victor Navarro; Juan Manuel Ferrero-Cafiero; Xavier González; Cristina Hernando; Alexios Matikas; Aleix Prat; Mafalda Oliveira; Tomas Pascual
errShare
errSave
Phase Ib study of xentuzumab and abemaciclib in patients with advanced solid tumors and in combination with endocrine therapy in patients with advanced breast cancer
errESMO Open
IF8.3
err2025-10-23
err0
errOAAI
errD. Yee; H. Iwata; P. LoRusso; M. Oliveira; A. Gonçalves; A. Stradella; M. Vidal; M.P. Sablin; M.C. Hardebeck; Y. Fukuyama; N. Forman; M. Puig; R.M. Lorence
errShare
errSave
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err4
PREAI
errCortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M.
errShare
errSave
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial
errESMO Open
IF8.3
err2025-09-01
err0
errOAAI
errT. Pascual; G. Villacampa; M. Oliveira; S. Escrivá-de-Romaní; S. Pernas; L. Paré; B. Adamo; E. Martínez; J. Cortés; A. Perelló; M. Galan; M. Melé; L. Villanueva; M. Gonzalez-Rodriguez; P. Tolosa; B. González-Farré; P. Galván; J. Canes; P. Nuciforo; J.M. Ferrero-Cafiero; X. González-Farré; P. Villagrasa; A. Prat; E. Ciruelos
errShare
errSave
Identifying germline pathogenic variants in breast cancer using tumor sequencing
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errCruellas, Mara; Papakonstantinou, Andri; Lopez-Fernandez, Adria; Castillo, Ester; Matito, Judit; Gomez, Marina; Rezqallah, Alejandra; Vega, Sharela; Navarro, Victor; Torres, Maite; Moles-Fernandez, Alejandro; Saura, Cristina; Vivancos, Ana; Balmana, Judith; Oliveira, Mafalda
errShare
errSave
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-04-17
err0
errOAAI
errPeter Schmid; Mafalda Oliveira; Joyce O’Shaughnessy; Massimo Cristofanilli; Stephanie L. Graff; Seock-Ah Im; Sherene Loi; Shigehira Saji; Shusen Wang; David W. Cescon; Tina Hovey; Agata Nawrot; Karson Tse; Petra Vukovic; Giuseppe Curigliano
errShare
errSave
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer
errFUTURE ONCOLOGY
IF2.6
err2024-09-16
err2
errOAAI
errTurner, Nicholas C.; Oliveira, Mafalda; Howell, Sacha J.; Dalenc, Florence; Cortes, Javier; Gomez, Henry L.; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Park, Yeon Hee; Sohn, Joo-Hyuk; Toi, Masakazu; Tokunaga, Eriko; Yousef, Samih; Zhukova, Lyudmila; de Bruin, Elza; Grinsted, Lynda; Schiavon, Gaia; Foxley, Andrew; Rugo, Hope S.
errShare
errSave
Interim analysis (IA) of the giredestrant (G) plus samuraciclib (SAMURA) arm in MORPHEUS breast cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errOliveira, M.; Gion Cortes, M.; Jung, K. H.; Bermejo, B.; Hurvitz, S. A.; Sadeghi, S.; Wander, S.; Im, S-A.; Gal-Yam, E.; Zhu, J.; Schwab, R.; Ngo, H.; Collier, A.; Cannon, M.; Cahuzac, C.; Moreno, P. D. Perez; Mcintosh, S.; Saavedra Serrano, C.; Sonnenblick, A.
errShare
errSave
Overall survival in first-line HRD/HER2-advanced breast cancer in the era of CDK4/6 inhibitors
errANNALS OF ONCOLOGY
IF65.4
err2024-08-01
err0
PREAI
errSanchez-Bayona, Rodrigo; Oliveira, Mafalda
errShare
errSave
Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial
errCLINICAL CANCER RESEARCH
IF10.2
err2024-07-26
err0
errOAAI
errDent, Rebecca A.; Kim, Sung-Bae; Oliveira, Mafalda; Barrios, Carlos; O'Shaughnessy, Joyce; Isakoff, Steven J.; Saji, Shigehira; Freitas-Junior, Ruffo; Philco, Manuel; Bondarenko, Igor; Lian, Qinshu; Bradley, Denise; Hinton, Heather; Wongchenko, Matthew J.; Reilly, Sarah-Jayne; Turner, Nicholas
errShare
errSave
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
errNATURE COMMUNICATIONS
IF15.7
err2024-07-11
err1
errOAAI
errBraso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda
errShare
errSave
Use of ctDNA in early breast cancer: analytical validity and clinical potential
errNPJ BREAST CANCER
IF7.6
err2024-06-19
err11
errOAAI
errPanet, Francois; Papakonstantinou, Andri; Borrell, Maria; Vivancos, Joan; Vivancos, Ana; Oliveira, Mafalda
errShare
errSave
EFFECTS OF THE COVID-19 PANDEMIC ON INGUINAL HERNIA SURGERY IN A SINGLE CENTER IN PORTUGAL: ANALYSIS OF EMERGENCY CASES AND TREATMENT PATTERNS
errBRITISH JOURNAL OF SURGERY
IF8.7
err2024-05-27
err0
errOAAI
errde Oliveira, G. Paiva; Oliveira, M.; Parreira, M. E.; Guimaraes, S.; Melo, J.; Branco, A.; Luz, C.
errShare
errSave
Characterizing Immune Infiltration in Metastatic Hormone Receptor-Positive/HER2Negative Breast Cancer: A Comprehensive Translational Analysis from four SOLTI Clinical Trials
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errSegui, Elia; Sanfeliu, Esther; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Salvador, Fernando; Angelats, Laura; Villanueva, Lorea; Espinosa, Alejandra; Galvan, Patricia; Fernandez, Esther; Gonzalez-Farre, Xavier; Escriva-De-Romani, Santiago; Chic, Nuria; Ciruelos, Eva; Saura, Cristina; Manso, Luis; Oliveira, Mafalda; Tabernero, Josep; Prat, Aleix; Pascual, Tomas
errShare
errSave
HER2-positive early breast cancer (EBC): treatment, toxicities and outcomes in a retrospective cohort of elderly patients (pts)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errRezqallah, Alejandra; Gomez-Puerto, Diego; Ranchor, Ridhi; Joval-Ramentol, Laia; Sanz, Lucia; Borrell, Maria; Alvarado-Cardenas, Marcelo; San-Jose, Antonio; Comas, Clara Morales; Espinosa-Bravo, Martin; Altabas, Manuel; Zamora, Esther; Ortiz, Carolina; Pardo, Patricia Gomez; Pimentel, Isabel; Bellet-Ezquerra, Meritxell; Oliveira, Mafalda; Saura, Cristina; Arumi, Miriam; Escriva-De-Romani, Santiago
errShare
errSave
Capivasertib and fulvestrant for patients with aromatase inhibitor-resistant HR positive/HER2-negative advanced breast cancer: exploratory analysis of PFS by AKT pathway gene from the Phase 3 CAPItello-291 trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err1
PREAI
errHowell, Sacha; Rugo, Hope; Oliveira, Mafalda; Dalenc, Florence; Cortes, Javier; Gomez, Henry; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Okera, Meena; Park, Yeon; Sohn, Joo Hyuk; Toi, Masakazu; Tokunaga, Eriko; Zhukova, Lyudmila; Lloyd, Andrew; de Bruin, Elza; Egile, Coumaran; D'Cruz, Celina; Turner, Nicholas
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
C
Charles M. Perou
H-index: 193 · Papers: 2.0K
G
Gabriel N. Hortobágyi
H-index: 187 · Papers: 1.9K
J
Jörge E. Cortes
H-index: 179 · Papers: 3.6K
E
Eric P. Winer
H-index: 170 · Papers: 1.6K
C
Carlos Caldas
H-index: 158 · Papers: 1.4K
View more